May 29, 2026 FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)
May 29, 2026 Blaze Pizza Celebrates National Best Friend Day With the Return of Its Fan-Favorite BFF Bundle
May 29, 2026 Rocky Mountain Chocolate Factory Schedules Fiscal Fourth Quarter and Full Year 2026 Conference Call for June 2, 2026 at 9:00 A.M. ET
May 29, 2026 Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy
